GlycoNex Submits Denosumab Biosimilar SPD8 for Regulatory Approval in Japan
Subject to regulatory review and approval, SPD8 could receive marketing approval in Japan by the end of 2027, paving the way for its commercial launch.
PMDA | 09/11/2026 | By Abha Rustagi
Shilpa Biologicals has launched PartnerPower, a proprietary platform offering real-time visibility into process development and Good Manufacturing Practice (GMP) manufacturing, setting a new benchmark for transparency in CDMO operations.
PMDA | 24/06/2026 | By News Bureau | 186
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy